Janice Kranz, Co-Founder of Eikonizo Therapeutics, brings over 25 years of invaluable experience in the biotech sector, particularly within startup environments. With a PhD in biology from Harvard, Janice has honed her expertise in drug discovery, biochemistry, and high-throughput screening, making her a pivotal figure...
Janice Kranz, Co-Founder of Eikonizo Therapeutics, brings over 25 years of invaluable experience in the biotech sector, particularly within startup environments. With a PhD in biology from Harvard, Janice has honed her expertise in drug discovery, biochemistry, and high-throughput screening, making her a pivotal figure in the advancement of innovative therapies for brain diseases. At Eikonizo, she is instrumental in leveraging cutting-edge PET imaging technology to enhance the drug discovery process, allowing the team to de-risk novel targets and lead candidates early on. This strategic approach not only accelerates the path to drug development but also significantly improves the likelihood of success in a notoriously challenging field.
Janice's proven track record in building successful collaborative research teams is evident in her leadership style, which fosters a culture of innovation and open communication. Her ability to work cross-functionally across business development, intellectual property, finance, and IT has been critical in navigating the complexities of startup operations. She excels in strategic financial planning and grant writing, securing essential funding to propel Eikonizo's ambitious projects forward.
Currently, Janice is spearheading key initiatives aimed at expanding the company's pipeline of therapeutic candidates, focusing on neurodegenerative diseases where traditional drug discovery methods have often fallen short. Her commitment to building relationships and collaboration within the scientific community ensures that Eikonizo remains at the forefront of biotechnological advancements, ultimately envisioning a future where effective treatments for brain diseases are not just a possibility, but a reality.
